18 Results for "

NKCC1

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "NKCC1" in MCE Product Catalog:

  • Targets Recommended:
19
19 Publications Verification
Cat. No.: HY-17468
CAS No.: 28395-03-1
Synonyms: Ro 10-6338; PF 1593
Target:  

NKCC

Bumetanide (Ro 10-6338; PF 1593), a highly potent loop diuretic, is a Na +-K +-Cl + cotransporter (NKCC) blocker. Bumetanide is a selective NKCC1 inhibitor, but also inhibits NKCC2, with IC50s of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1] .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B0135
CAS No.: 54-31-9
Furosemide is a potent and orally active inhibitor of Na +/K +/2Cl - (NKCC) cotransporter, NKCC1 and NKCC2 [1]. Furosemide is also a GABAA receptors antagonist and displays 100-fold selectivity for α6-containing receptors than α1-containing receptors. Furosemide acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B0135A
CAS No.: 41733-55-5
Furosemide sodium is a potent and orally active inhibitor of Na +/K +/2Cl - (NKCC) cotransporter, NKCC1 and NKCC2 [1]. Furosemide sodium is also a GABAA receptors antagonist and displays 100-fold selectivity for α6-containing receptors than α1-containing receptors. Furosemide sodium acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107321
CAS No.: 27589-33-9
Purity:  99.85%
Target:  

NKCC

Research Areas:  

Metabolic Disease

Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246 μM and 0.197 μM for hNKCC1A and NKCC1B, respectively [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16689
CAS No.: 893990-34-6
Target:  

Potassium Channel

Research Areas:  

Others

VU 0240551 is a potent neuronal K-Cl cotransporter KCC2 inhibitor (IC50=560 nM) and is selective versus NKCC1. VU 0240551 also inhibits hERG and L-type Ca 2+ channels. VU 0240551 attenuates GABA-induced hyperpolarization of P cells, produces a positive shift in the P cell GABA reversal potential and enhances P cell synaptic transmission [1] .
loading...
    loading...
Cat. No.: HY-110143
CAS No.: 1181081-71-9
Purity:  99.31%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

CLP257 is a selective K +-Cl cotransporter KCC2 activator with an EC50 of 616 nM. CLP257 is inactive against NKCC1, GABAA receptors, KCC1, KCC3 or KCC4. CLP257 restores impaired Cl transport in neurons with diminished KCC2 activity. CLP257 alleviates hypersensitivity in rats with neuropathic pain. CLP257 modulates plasmalemmal KCC2 protein turnover post-translationally [1] .
loading...
    loading...
Cat. No.: HY-172318
CAS No.: 2497525-96-7
Target:  

NKCC

Research Areas:  

Neurological Disease

IAMA-6 is a selective NKCC1 inhibitor with neuroprotective effects. IAMA-6 can be used for the study of brain conditions, including drug-resistant epilepsy (e.g. temporal lobe epilepsy (TLE) and Dravet syndrome (DrS)), autism spectrum disorders (ASD) and Down syndrome (DoS) [1].
loading...
    loading...
Cat. No.: HY-B0135S
CAS No.: 1189482-35-6
Furosemide-d5 is the deuterium labeled Furosemide. Furosemide is a potent and orally active inhibitor of Na+/K+/2Cl-?(NKCC) cotransporter, NKCC1 and NKCC2 [1].?Furosemide is also a GABAA?receptors antagonist and displays 100-fold selectivity for?α6-containing receptors than?α1-containing receptors. Furosemide acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema .
loading...
    loading...
Cat. No.: HY-17468R
CAS No.: 28395-03-1
Synonyms: Ro 10-6338 (Standard); PF 1593 (Standard)
Bumetanide (Standard) is the analytical standard of Bumetanide. This product is intended for research and analytical applications. Bumetanide (Ro 10-6338; PF 1593), a highly potent loop diuretic, is a Na +-K +-Cl + cotransporter (NKCC) blocker. Bumetanide is a selective NKCC1 inhibitor, but also inhibits NKCC2, with IC50s of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1] .
loading...
    loading...
Cat. No.: HY-B0135R
CAS No.: 54-31-9
Furosemide (Standard) is the analytical standard of Furosemide. This product is intended for research and analytical applications. Furosemide is a potent and orally active inhibitor of Na +/K +/2Cl - (NKCC) cotransporter, NKCC1 and NKCC2 [1]. Furosemide is also a GABAA receptors antagonist and displays 100-fold selectivity for α6-containing receptors than α1-containing receptors. Furosemide acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema .
loading...
    loading...
Cat. No.: HY-18172
CAS No.: 1228439-36-8
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

KCC2 blocker 1 is an orally active and selective K +-Cl - cotransporter KCC2 blocker with an IC50 of 1 μM. KCC2 blocker 1 is a benzyl prolinate [1].
loading...
    loading...
Cat. No.: HY-17468S
CAS No.: 1216739-35-3
Bumetanide-d5 is a deuterium labeled Bumetanide. Bumetanide is a selective Na+-K+-Cl- (NKCC1) inhibitor, weakly inhibits NKCC2, with ?IC50s of 0.68 and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1].
loading...
    loading...
Cat. No.: HY-107321R
CAS No.: 27589-33-9
Research Areas:  

Metabolic Disease

Azosemide (Standard) is the analytical standard of Azosemide. This product is intended for research and analytical applications. Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246 μM and 0.197 μM for hNKCC1A and NKCC1B, respectively [1].
loading...
    loading...
Cat. No.: HY-17468A
CAS No.: 28434-74-4
Synonyms: Ro 10-6338 sodium; PF 1593 sodium
Target:  

NKCC

Bumetanide sodium, a highly potent loop diuretic, is a Na +-K +-Cl + cotransporter (NKCC) blocker. Bumetanide sodium is a selective NKCC1 inhibitor, and also inhibits NKCC2, with IC50s of 0.68 and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1] .
loading...
    loading...
Cat. No.: HY-115606
CAS No.: 1135304-61-8
Research Areas:  

Neurological Disease

ML007 is a selective antagonist targeting the neuron-specific potassium-chloride co-transporter 2 (KCC2) with an IC50 for KCC2 is 537 nM, while its inhibitory activity on KCC1 is extremely weak (IC50 > 50 μM). ML077 inhibits the chloride ion excretion function of KCC2, increasing the intracellular chloride ion concentration, thereby enhancing the depolarization mediated by chloride ion channels. ML007 can promote glucose-stimulated insulin secretion (GSIS) without relying on KATP channels. ML007 can be used to study the functions related to pain, epilepsy, and insulin secretion [1] .
loading...
    loading...
Cat. No.: HY-18172A
CAS No.: 1228439-71-1
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

(+)-KCC2 blocker 1 is a selective K +-Cl - cotransporter KCC2 blocker with an IC50 of 0.4 μM. (+)-KCC2 blocker 1 is a benzyl prolinate and a enantiomer of KCC2 blocker 1 [1].
loading...
    loading...
Cat. No.: HY-B0135AR
CAS No.: 41733-55-5
Furosemide (sodium) (Standard) is the analytical standard of Furosemide (sodium). This product is intended for research and analytical applications. Furosemide sodium is a potent and orally active inhibitor of Na+/K+/2Cl- (NKCC) cotransporter, NKCC1 and NKCC2 [1]. Furosemide sodium is also a GABAA receptors antagonist and displays 100-fold selectivity for α6-containing receptors than α1-containing receptors. Furosemide sodium acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema .
loading...
    loading...
Cat. No.: HY-RS12997
Research Areas:  

Others

SLC12A2 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC12A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
  • 1